TPD52 is expressed at a high level whereas miR-133a at a low level in pancreatic cancer tissues, both of which are related to the low differentiation, TNM III-IV stage and short survival time of patients with pancreatic cancer. This evidence concerns the gene TPD52 and familial pancreatic carcinoma.